VIDEO: ‘Exciting’ new CAR T developments presented at ASH
Click Here to Manage Email Alerts
Ryan Cassaday, MD, associate professor at University of Washington & Fred Hutchinson Cancer Research Center and attending physician at Seattle Cancer Care Alliance, discussed emerging strategies and developments in HIV malignancies, CD-22 targeted CAR T-cells and other presentations at the ASH Annual Meeting and Exposition.
“There's a fairly large effort from the group at Stanford by John Baird and others looking at CD-22 targeted CAR T-cells for children and adults with relapsed refractory B-cell ALL. In terms of the CAR T-cell field, one of the more exciting things is to get a flavor of where the field is moving and what different groups are doing to try to take the next step to either make this therapy more practical, safer, have faster turnaround and more effective,” Cassaday told Healio.
Collapse
Baird, J et al. Abstract . Presented at: ASH Annual Meeting and Exposition (virtual meeting); Dec. 5-8, 2020.
Read more about
Click Here to Manage Email Alerts